3,294
Participants
Start Date
November 30, 2015
Primary Completion Date
November 1, 2017
Study Completion Date
November 1, 2017
Harvoni
Harvoni (90/400 mg) FDC tablet administered orally once daily
Ageo-shi
Akita
Amagasaki-shi
Aomori
Arao-shi
Asahi-shi
Asahikawa-shi
Asakura-shi
Bunkyō City
Chiba
Chichibu-shi
Chuo-shi
Fujioka-shi
Fukui-shi
Fukuoka
Gifu
Hakodate-shi
Hamamatsu
Handa-shi
Hashima-shi
Hatsukaichi-shi
Higashiibaraki-gun
Hirosaki-shi
Hiroshima
Hitachi-shi
Hukui-shi
Ichikawa-shi
Iizuka-shi
Ikeda-shi
Inashiki-gun
Inzai-shi
Iruma-gun
Ise-shi
Iwaki
Izumo-shi
Izunokuni-shi
Kagoshima
Kamogawa-shi
Kanazawa
Karatsu-shi
Kashihara-shi
Kashiwa-shi
Kasukabe-shi
Kawagoe-shi
Kawaguchi-shi
Kawasaki-shi
Kirishima-shi
Kitakyushu-shi
Kitamoto-shi
Kobe
Kodaira-shi
Kofu
Komae-shi
Komaki-shi
Koriyama-shi
Koshigaya-shi
Kōtoku
Kuga-gun
Kuki-shi
Kumamoto
Kurashiki-shi
Kure-shi
Kurume-shi
Kyoto
Maebashi
Matsumoto-shi
Matsuyama
Minatoku
Miyazaki
Moriguchi-shi
Morioka
Nagakute-shi
Nagasaki
Nagoya
Nakagami-gun
Nerima-ku
Niigata
Nishinomiya-shi
Noshiro
Obihiro-shi
Ofukeshi
Okayama
Osaka
Osakasayama-shi
Oume-shi
Ōita
Ōmihachiman
Ōta-ku
Ōtsu
Saga
Saitama-shi
Sakaishi
Sano-shi
Sapporo
Sasebo-Shi
Sendai
Shimonoseki-shi
Shimotsuga-gun
Shimotsuke-shi
Shinagawa-ku
Shinjuku-ku
Shirakawa-shi
Shizuoka
Shunan-shi
Sumida-ku
Tagawa-shi
Takamatsu
Takasaki-shi
Toda-shi
Tokorozawa-shi
Tokushima
Tonami-shi
Toyama
Toyoake-shi
Ureshino-shi
Utsunomiya
Wakayama
Yachiyo-shi
Yamagata
Yanagawa-shi
Yatsushiro-shi
Yokkaichi-shi
Yokohama
Yonago-shi
Yoshida-gun
Lead Sponsor
Gilead Sciences
INDUSTRY